About this trial
Peri-implantitis is an inflammatory disease affecting the tissues around dental implants and may lead to progressive bone loss and implant failure. Current diagnosis is mainly based on clinical and radiographic findings, which may not fully reflect the underlying inflammatory activity. Therefore, there is a need for biological markers that may provide additional information about disease-related changes.
This observational study aims to compare the levels of Meteorin-like protein (Metrnl) and selected inflammatory cytokines in peri-implant crevicular fluid obtained from individuals with peri-implantitis and individuals with healthy implants. The study will evaluate Metrnl, interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-10 (IL-10). It will also examine the relationships between Metrnl and these inflammatory markers.
The study hypothesis is that Metrnl levels differ between healthy peri-implant tissues and peri-implantitis and are associated with pro-inflammatory and anti-inflammatory cytokine levels. The findings may help clarify the possible role of Metrnl in peri-implant inflammation and its potential as a biomarker for distinguishing peri-implant health from peri-implantitis.
Eligibility criteria
Qualifiers
Individuals aged 18 years or older
Individuals without systemic disease
Individuals with at least one healthy implant or one implant affected by peri-implantitis
At least 1 year having elapsed since placement of the prosthetic restoration on the relevant implant
Disqualifiers
Pregnant or lactating individuals.
Current smokers.
Use of antibiotics or corticosteroids within the previous 6 months.
Presence of an implant-supported removable prosthesis.
Trial design
Treatments tested in this trial
- Not listed